The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-((R)-Carbamoylphenylmethyl)-N-((S)-2,3-dihydrobenzofuran-3-yl)benzamide ID: ALA4763338
PubChem CID: 118935313
Max Phase: Preclinical
Molecular Formula: C23H20N2O3
Molecular Weight: 372.42
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: NC(=O)[C@@H](c1ccccc1)N(C(=O)c1ccccc1)[C@@H]1COc2ccccc21
Standard InChI: InChI=1S/C23H20N2O3/c24-22(26)21(16-9-3-1-4-10-16)25(23(27)17-11-5-2-6-12-17)19-15-28-20-14-8-7-13-18(19)20/h1-14,19,21H,15H2,(H2,24,26)/t19-,21-/m1/s1
Standard InChI Key: WWINCCOXBCZASU-TZIWHRDSSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
33.2393 -11.7461 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2381 -12.5697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9503 -12.9828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6641 -12.5692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6613 -11.7425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9485 -11.3372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9501 -13.8041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2382 -14.2126 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.6618 -14.2129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3738 -13.8045 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.6616 -15.0342 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.5264 -13.8038 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2380 -15.0339 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.5260 -15.4464 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.8185 -15.6133 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6056 -16.4046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1812 -16.9796 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9727 -16.7683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1813 -15.9726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6042 -15.4010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4367 -12.9923 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6335 -12.8235 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.7753 -14.1438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2277 -13.5377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4310 -13.7094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.1808 -14.4868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7335 -15.0926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5281 -14.9177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 3 1 6
7 8 1 0
7 9 1 0
9 10 1 0
9 11 2 0
12 8 1 1
8 13 1 0
13 14 2 0
13 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
12 21 1 0
21 22 1 0
22 24 1 0
23 12 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 372.42Molecular Weight (Monoisotopic): 372.1474AlogP: 3.49#Rotatable Bonds: 5Polar Surface Area: 72.63Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 3.33CX LogD: 3.33Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.75Np Likeness Score: -0.56
References 1. Kobayashi JI,Hirasawa H,Fujimori Y,Nakanishi O,Kamada N,Ikeda T,Yamamoto A,Kanbe H. (2021) Identification of N-acyl-N-indanyl-α-phenylglycinamides as selective TRPM8 antagonists designed to mitigate the risk of adverse effects., 30 [PMID:33333445 ] [10.1016/j.bmc.2020.115903 ]